First Gene Therapy Approved for Hearing Loss

(MedPage Today) -- The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene therapy, lunsotogene parvec...
Source
MedPage Today
Opens original article in a new tab



